1. Shin S, Shin YJ, Ki M. Cost-benefit analysis of haemophilus influenzae type B immunization in Korea. J Korean Med Sci. 2008. 23:176–184.
Article
6. Zhou F, Bisgard KM, Yusuf HR, Deuson RR, Bath SK, Murphy TV. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis. Pediatrics. 2002. 110:653–661.
Article
7. Gessner BD, Sutanto A, Linehan M, Djelantik IG, Fletcher T, Gerudud IK, Ingerani , Mercer D, Moniaga V, Moulton LH, Moulton LH, Mulholland K, Nelson C, Soemohardjo S, Steinhoff M, Widjaya A, Stoeckel P, Maynard J, Arjoso S. Incidences of vaccine-preventable Haemophilus Influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine probe trial. Lancet. 2005. 365:43–52.